In the last trading session, 3.84 million Biohaven Ltd (NYSE:BHVN) shares changed hands as the company’s beta touched 3.67. With the company’s per share price at $16.02 changed hands at $0.2 or 1.26% during last session, the market valuation stood at $1.64B. BHVN’s last price was a discount, traded about -247.69% off its 52-week high of $55.70. The share price had its 52-week low at $14.69, which suggests the last value was 8.3% up since then.
Analysts gave the Biohaven Ltd (BHVN) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.12. If we narrow down to specifics, the data shows that 0 out of 7 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended BHVN as a Hold, 7 felt it is a Buy and 0 rated the stock as Underweight.
Biohaven Ltd (NYSE:BHVN) trade information
Instantly BHVN was in green as seen at the end of in last trading. With action -20.85%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -57.11%, with the 5-day performance at -20.85% in the red. However, in the 30-day time frame, Biohaven Ltd (NYSE:BHVN) is -14.24% down.
The consensus price target for the stock as assigned by Wall Street analysts is 60, meaning bulls need an upside of 73.3% from its current market value. According to analyst projections, BHVN’s forecast low is 57 with 61 as the target high. To hit the forecast high, the stock’s price needs a -280.77% plunge from its current level, while the stock would need to soar -255.81% for it to hit the projected low.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -49.78%. The 2025 estimates are for Biohaven Ltd earnings to increase by 19.78%, but the outlook for the next 5-year period is at 18.68% per year.
BHVN Dividends
Biohaven Ltd is expected to release its next quarterly earnings report in June.
STIFEL FINANCIAL CORP holds the second largest percentage of outstanding shares, with 7.3839% or 6.48 million shares worth $224.94 million as of 2024-06-30.
Among Mutual Funds, the top two as of Dec 31, 2024 were VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF . With 2.51 shares estimated at $40.22 million under it, the former controlled 2.46% of total outstanding shares. On the other hand, iShares Trust-iShares Russell 2000 ETF held about 2.21% of the shares, roughly 2.26 shares worth around $36.23 million.
